News & Publications

News

Deals & Cases

Walder Wyss advises BC Platforms on $15 million Series C Financing and on a Partnership with IQVIA to Extend Data Analytics in Genomics

17 December 2019 – BC Platforms announced that it has closed a USD 15 million financing round alongside a new commercial collaboration with IQVIA™ (NYSE: IQV). The round was led by IQVIA in conjunction with Debiopharm Innovation Fund and Tesi, a Finnish venture capital and private equity company. As part of the collaboration, IQVIA and BC Platforms plan to launch new data driven technologies, integrating complex clinical and genomic data.

BC Platforms is a world leader in genomic data management and analytics. Through the commercial collaboration between IQVIA and BC Platforms, the partners plan to build a world leading analytics platform to enable the pharmaceutical industry’s advancement of precision medicine. BC Platforms will use the fundraising proceeds to expand its global network of clinical and genomics data. BC Platforms is headquartered in Zurich, Switzerland.

Walder Wyss acted as advisor to BC Platforms in this transaction. The team was being led by Alexander Gutmans (Partner, Corporate/M&A), Markus Vischer (Partner, Corporate/M&A) and included Markus Schülin (Counsel, Notary Public), Rafael Zemp (Managing Associate, Corporate/M&A), Nico Bernhard (Associate, Corporate/M&A) and Karina Tschon (Associate, Corporate/M&A).

Technically necessary cookies

Essential technical cookies are necessary for the flawless functioning of our website and cannot be disabled.
Cookies for statistics

Analytical cookies enable us to count visits and traffic sources, allowing us to measure and enhance the performance of our website. They assist us in answering questions such as which pages are the most popular, which are the least used, and how visitors navigate the website. All information collected by these cookies is aggregated and therefore anonymous.
Marketing cookies may be set by our advertising partners on our website. These companies can use them to create a profile of your interests and display relevant advertisements on other websites. They operate by uniquely identifying your browser and device. By activating these cookies, you acknowledge and consent to the information collected by such cookies being sent to providers outside of Switzerland and the EU, including countries with (from the perspective of Swiss data protection law) inadequate data protection (e.g., the United States, Singapore, and Taiwan). You also acknowledge that data transmitted abroad is no longer protected by Swiss law, and foreign laws as well as regulatory orders may require the disclosure of this data to authorities and other third parties.

Marketing cookies may be set by our advertising partners on our website. These companies can use them to create a profile of your interests and display relevant advertisements on other websites. They operate by uniquely identifying your browser and device. By activating these cookies, you acknowledge and consent to the information collected by such cookies being sent to providers outside of Switzerland and the EU, including countries with (from the perspective of Swiss data protection law) inadequate data protection (e.g., the United States, Singapore, and Taiwan). You also acknowledge that data transmitted abroad is no longer protected by Swiss law, and foreign laws as well as regulatory orders may require the disclosure of this data to authorities and other third parties.